Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Return on Assets [ROA] (2011 - 2016)

Updated

Kazia Therapeutics (KZIA) posted Return on Assets [ROA] of -154.36% for FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Return on Assets [ROA] (2011 - 2016) Analysis & Trends

Since FY2009, Kazia Therapeutics has reported Return on Assets [ROA] for 16 fiscal years.

  • Annual Return on Assets [ROA] shows a five-year change of -103.06 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Return on Assets [ROA] since FY2014.
  • Business Quant data shows KZIA's Return on Assets [ROA] at -127.25% in FY2024 (-55.22 pp), -72.04% in FY2023 (-1.04 pp), -71.00% in FY2022 (-45.47 pp) and -25.52% in FY2021 (+25.77 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.08%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 7.32%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.87%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.36%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 9.80%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -7.67%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.00%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -96.93%
Dec 31, 2015 -54.35%
Sep 10, 2015 -52.81%
Dec 31, 2014 -66.36%
Dec 31, 2013 17.73%
Aug 30, 2013 57.43%
Dec 31, 2012 467.70%
Dec 31, 2011 142.65%
API Access

Kazia Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KZIA&period=max&api_key=YOUR_API_KEY